Zhan-Miao Yi (Zhanmiao Yi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Peritoneal Dialysis

Ejection Fraction

Bipolar Disorder

Top Venues

CNS neuroscience & therapeutics

Expert review of pharmacoeconomics & outcomes research

Clinical pharmacokinetics

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Zhan-Miao Yi, Xinya Li, Zhitong Wang, Jiguang Qin, Dan Jiang, Panhui Tian, Ping Yang, Rongsheng Zhao
Status and Quality of Guidelines for Therapeutic Drug Monitoring Based on AGREE II Instrument. Clinical pharmacokinetics (2023)
Qingli Meng, Hong-Yan Gu, Qinghua Zhang, Zhan-Miao Yi, Dechun Jiang
Carbamazepine cutaneous adverse reactions and HLA gene variation in the Chinese population: a systematic review and meta-analysis. Pharmacogenomics (2023)
Wenting Li, Hua Zhang, Yuan Zhang, Ke Wang, Jiaojiao Hui, Zhan-Miao Yi
Comparison of the effectiveness, safety, and costs of anti-Parkinson drugs: A multiple-center retrospective study. CNS neuroscience & therapeutics (2023)
Zhan-Miao Yi, Peng Men, Shuli Qu, Chaoyun Li, Xin Yu, Suodi Zhai
Comparative cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China. Expert review of pharmacoeconomics & outcomes research 20 (3) (2020)